Diabetes Dialogue: Technology, Therapeutics, & Real-World Pe...

What's New at Medtronic Diabetes With Bob Vigersky, MD

Results of ATTAIN-1 and STEP UP Phase 3 Trials

Semaglutide & Tirzepatide Updates at ESC Congress 2025

FDA Approves Semaglutide (Wegovy) for MASH

ADCES 2025 Part 3 & Diabetes Tech Updates

ADCES 2025 Recap Part 2

Orforglipron Topline Results & ADCES 2025 Part 1

Tirzepatide and SURPASS-CVOT Topline Results

Guideline Updates for Diabetes & Pregnancy

GLP-1s, SGLT2s, and Diabetes Barbie at ENDO 2025

Upcoming Research on Type 1 Diabetes in Pregnancy with Carol Levy, MD

BELIEVE, GLP-1/GIP Agonists, and CATALYST Results at ADA 2025

American Diabetes Association 2025 Trial Recap - Part 1

The Diabetes Collective, with Rachael Sood, RN, MSN, APRN

Addressing America's Shortage of Diabetes Care Providers, with Jay Shubrook, DO, & Conan Tu, MD

CATALYST Trial, Mifepristone, and Hypercortisolism in T2D, with John Buse, MD, PhD

Updates from Dexcom at ADA 2025, with Kevin Sayer

Patient Considerations for Inhaled Insulin, with Carol Levy, MD

ADA 2024 Diabetes Technology Recap

June 2024 Updates in Diabetes Technology and T1D

GLAM and CRISTAL, Updates in Pregnancy

FLOW Trial and Semaglutide's Benefit in Chronic Kidney Disease

2024 ACP Type 2 Diabetes Recommendations

STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

What to Know about Sequel Med Tech's twiist AID System, with Alan Lotvin, MD

Hot Topics and Updates from ATTD 2024

T1D Glycemic Improvement and CRISTAL at ATTD 2024

FLOW Trial and Chronic Kidney Disease Updates, with Brendon Neuen, MBBS, PhD

Dexcom Stelo and CGM Updates, with Jake Leach

Tirzepatide and the Future of Incretin Therapies, with Timothy Garvey, MD

SELECT, Semaglutide, & the Future of Incretin Therapies, with A. Michael Lincoff, MD

Understanding MARD, Comparing Popular CGM Sensors

ATTD 2024 Preview

Time in Range, CGM Metrics for Predicting Outcomes in Diabetes

Tirzepatide in Type 1 Diabetes, with Viral Shah, MD

Diabetes Technology Updates in January 2024

Updates in Management of Hypercortisolism in Type 2 Diabetes, with Ralph DeFronzo, MD

Latest Updates on Diabetes Management in Pregnancy

Baricitinib & the Potential Disease-Modifying Therapies in Type 1 Diabetes

Diabetes Dialogue: 2023 Top Episodes Recap

Key Updates in ADA Standards of Care—2024

Diabetes Technology Updates and Standards of Care—2024

SELECT Proves Semaglutide 2.4 mg CV Benefit at AHA 2023

Tirzepatide (Zepbound) Approved for Chronic Weight Management

Diabetes Dialogue: Automated Insulin Delivery News in October 2023

SURMOUNT-3 and SURMOUNT-4 Data

PROTECT Data and Teplizumab in Newly Diagnosed T1D

Accu-Chek Solo and Abbott Acquiring Bigfoot Biomedical

Making Sense of Semaglutide in Type 1 Diabetes

Clearance of Tandem Mobi and Welldoc's BlueStar Platform